YU48415B - PROCEDURE FOR OBTAINING PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING CEPHALOSPORIN AND XANTINE DERIVATIVES - Google Patents

PROCEDURE FOR OBTAINING PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING CEPHALOSPORIN AND XANTINE DERIVATIVES

Info

Publication number
YU48415B
YU48415B YU108291A YU108291A YU48415B YU 48415 B YU48415 B YU 48415B YU 108291 A YU108291 A YU 108291A YU 108291 A YU108291 A YU 108291A YU 48415 B YU48415 B YU 48415B
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical combination
procedure
preparations containing
combination preparations
obtaining pharmaceutical
Prior art date
Application number
YU108291A
Other languages
Serbo-Croatian (sh)
Other versions
YU108291A (en
Inventor
Klesel
Limbert
Schrinner
Original Assignee
Taiho Pharmaceutical Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co. Ltd. filed Critical Taiho Pharmaceutical Co. Ltd.
Priority to HRP-1082/91A priority Critical patent/HRP940708B1/en
Publication of YU108291A publication Critical patent/YU108291A/en
Publication of YU48415B publication Critical patent/YU48415B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Pharmaceutical combination products containing at least one cephalosporin derivative and at least one xanthine derivative are suitable for the prophylaxis and treatment of bacterial infectious diseases and for the prophylaxis and treatment of septic shock.
YU108291A 1990-06-20 1991-06-19 PROCEDURE FOR OBTAINING PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING CEPHALOSPORIN AND XANTINE DERIVATIVES YU48415B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-1082/91A HRP940708B1 (en) 1990-06-20 1994-10-19 Pharmaceutical preparations of mixtures comprising derivatives of cephalosporin and xantine and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4019571A DE4019571A1 (en) 1990-06-20 1990-06-20 PHARMACEUTICAL COMBINATION PRODUCTS CONTAINING CEPHALOSPORINE AND XANTHINE DERIVATIVES AND THEIR USE

Publications (2)

Publication Number Publication Date
YU108291A YU108291A (en) 1995-03-27
YU48415B true YU48415B (en) 1998-07-10

Family

ID=6408686

Family Applications (1)

Application Number Title Priority Date Filing Date
YU108291A YU48415B (en) 1990-06-20 1991-06-19 PROCEDURE FOR OBTAINING PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING CEPHALOSPORIN AND XANTINE DERIVATIVES

Country Status (26)

Country Link
US (1) US5350753A (en)
EP (1) EP0462506B1 (en)
JP (1) JP3213339B2 (en)
KR (1) KR100205161B1 (en)
CN (1) CN1057390A (en)
AT (1) ATE144901T1 (en)
AU (1) AU643291B2 (en)
BR (1) BR9102554A (en)
CA (1) CA2044977A1 (en)
CZ (1) CZ282285B6 (en)
DE (2) DE4019571A1 (en)
DK (1) DK0462506T3 (en)
ES (1) ES2093656T3 (en)
FI (1) FI912968A (en)
GR (1) GR3021568T3 (en)
HR (1) HRP940708B1 (en)
HU (1) HU212937B (en)
IE (1) IE76290B1 (en)
IL (1) IL98535A (en)
MX (1) MX26309A (en)
NO (1) NO912382L (en)
NZ (1) NZ238580A (en)
PT (1) PT98028B (en)
RU (1) RU2095063C1 (en)
YU (1) YU48415B (en)
ZA (1) ZA914709B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1090795A (en) 1993-11-12 1995-05-29 Cell Therapeutics, Inc. Method for preventing tissue injury from hypoxia
ES2185837T3 (en) * 1996-06-07 2003-05-01 Hoechst Ag USE OF THEOPHYLIN DERIVATIVES FOR THE TREATMENT AND PROFILAXIS OF SHOCK DISEASES, NEW XANTINE COMPOUNDS AND PROCEDURES FOR PRODUCTION.
JP2006510357A (en) * 2002-11-22 2006-03-30 ザ ジョーンズ ホプキンズ ユニバーシティ Targets for the treatment of cognitive impairment
KR101315483B1 (en) * 2011-06-23 2013-10-07 주식회사 아리바이오 A composition comprising antibiotics and lysophosphatidylcholine for enhancing immune or treating bacterial infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3817955A1 (en) * 1988-05-27 1989-11-30 Hoechst Ag MEDICINAL PRODUCT CONTAINING TNF INHIBITOR

Also Published As

Publication number Publication date
IL98535A0 (en) 1992-07-15
JP3213339B2 (en) 2001-10-02
EP0462506B1 (en) 1996-11-06
NZ238580A (en) 1993-10-26
YU108291A (en) 1995-03-27
DK0462506T3 (en) 1996-11-25
IE76290B1 (en) 1997-10-08
HRP940708A2 (en) 1997-02-28
AU643291B2 (en) 1993-11-11
EP0462506A1 (en) 1991-12-27
GR3021568T3 (en) 1997-02-28
HUT57986A (en) 1992-01-28
DE59108321D1 (en) 1996-12-12
FI912968A (en) 1991-12-21
PT98028B (en) 1998-11-30
JPH04230219A (en) 1992-08-19
AU7848291A (en) 1992-01-02
ES2093656T3 (en) 1997-01-01
CZ282285B6 (en) 1997-06-11
IE912107A1 (en) 1992-01-01
DE4019571A1 (en) 1992-01-02
MX26309A (en) 1994-02-28
NO912382L (en) 1991-12-23
PT98028A (en) 1992-03-31
CN1057390A (en) 1992-01-01
HU912048D0 (en) 1991-12-30
IL98535A (en) 1996-01-19
RU2095063C1 (en) 1997-11-10
ATE144901T1 (en) 1996-11-15
FI912968A0 (en) 1991-06-18
HRP940708B1 (en) 1998-12-31
HU212937B (en) 1996-12-30
CA2044977A1 (en) 1991-12-21
BR9102554A (en) 1992-01-21
KR100205161B1 (en) 1999-07-01
CS187891A3 (en) 1992-02-19
US5350753A (en) 1994-09-27
NO912382D0 (en) 1991-06-19
ZA914709B (en) 1992-03-25
KR920000322A (en) 1992-01-29

Similar Documents

Publication Publication Date Title
NZ217016A (en) Zwitterionic bicyclic heterocyclic compounds, and pharmaceutical compositions containing such
NO891703L (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PSORIASIS.
YU48415B (en) PROCEDURE FOR OBTAINING PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING CEPHALOSPORIN AND XANTINE DERIVATIVES
FI884960A (en) ANVAENDNING AV 2-PYRIMIDINYL-1-PIPERAZINE DERIVATIVES.
NO922635D0 (en) NEW USE OF BENZIMIDAZOLINE-2-OXO-1-CARBOXYLIC ACID DERIVATIVES
DK0457215T3 (en) 3-deamino-4-deoxy-4-amino-8-fluoroanthracyclines and methods for their preparation
IT9019882A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING GLYCEROL-5- PHOSPHATE DERIVATIVES SUITABLE FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM
ATE90565T1 (en) TREATMENT OF SHOCK WITH CYCLODEXTRIN AND ITS DERIVATIVES.
IT1248485B (en) Derivatives of the 1,4-benzothiazine with immunostimulant and immunomodulatory activity
ITMI920878A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING MONOSIAL-GANGLIOSIDIC DERIVATIVES SUITABLE FOR THE TREATMENT OF DAMAGE TO THE SPINAL CORD.
TR199701299A2 (en) Vinylpyrrolidone cephalasporin derivatives.
ITMI910881A0 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING GLYCEROL-3-PHOSPHATE DERIVATIVES SUITABLE FOR THE TREATMENT OF NERVOUS SYSTEM DISEASES